WisdomTree BioRevolution Fund (WDNA)

BATS: WDNA · Real-Time Price · USD

22.57

-0.22 (-0.96%)

At close: Nov 13, 2026, 4:00 PM EST

22.54

-0.03 (-0.12%)

After-hours: Nov 13, 2026, 8:00 PM EST

Assets	$4.93M
Expense Ratio	0.45%
PE Ratio	23.91
Forward PE	17.97
Shares Out	210,000
Dividend	$0.77 (3.41%)
Ex-Dividend Date	Dec 26, 2025
Payout Frequency	Annual
Payout Ratio	79.15%

Volume	581
Open	22.90
Previous Close	22.79
Day's Range	22.54 - 22.90
52-Week Low	16.11
52-Week High	25.03
Beta	1.01
Holdings	90
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

Asset Class Equity

Category Health

Stock Exchange Cboe BZX

Ticker Symbol WDNA

ETF Provider WisdomTree

Index Tracked WisdomTree BioRevolution Index

Top 10 Holdings

28.21% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	3.97%
Tempus AI, Inc.	TEM	3.61%
Moderna, Inc.	MRNA	3.04%
Immunome, Inc.	IMNM	3.00%
Twist Bioscience Corporation	TWST	2.84%
Thermo Fisher Scientific Inc.	TMO	2.64%
Natera, Inc.	NTRA	2.50%
Stoke Therapeutics, Inc.	STOK	2.39%
United Therapeutics Corporation	UTHR	2.30%
10x Genomics, Inc.	TXG	1.93%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.77052	Dec 30, 2025
Dec 26, 2024	$0.1071	Dec 30, 2024
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021

Full Dividend History

Performance

WDNA had a total return of 40.31% in the past year, including dividends. Since the fund's inception, the average annual return has been -0.63%.